LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

Core Insights - LENSAR, Inc. reported significant growth in its financial performance for the fourth quarter and full year of 2024, with total revenue increasing by 38% in Q4 and 27% for the full year compared to 2023 [1][10] - The company placed 31 ALLY Robotic Cataract Laser Systems in Q4 2024, leading to a total of over 80 placements for the year, which contributed to a recurring revenue exceeding $40 million, a 23% increase from 2023 [1][2] - Despite the revenue growth, LENSAR reported a net loss of $18.7 million in Q4 2024, significantly higher than the $3.9 million loss in Q4 2023, primarily due to changes in warrant liabilities linked to stock price appreciation [7][16] Financial Performance - Total revenue for Q4 2024 was $16.7 million, up from $12.1 million in Q4 2023, driven by increased sales of ALLY Systems and higher procedure volumes [3] - For the full year 2024, total revenue reached $53.5 million, compared to $42.2 million in 2023, with procedure volumes in the U.S. increasing by approximately 21% year-over-year [10] - Recurring revenue for the full year exceeded $40 million, with a 23% increase over 2023, indicating a strong growth in the company's service and procedure revenue streams [1][11] Operational Metrics - The total installed base of LENSAR systems increased to approximately 385 by the end of 2024, reflecting a 26% increase from 2023 [1][10] - Worldwide procedure volumes grew by 24% in 2024, with nearly 170,000 procedures performed, marking a significant increase in market activity [2] - The company achieved a market share of over 20% in the U.S. procedure market for the first time, with approximately 75% of U.S. placements being new to LENSAR users [2] Expenses and Losses - Selling, general, and administrative expenses for Q4 2024 were $6.8 million, a 7% increase from $6.4 million in Q4 2023, primarily due to increased marketing expenses to support ALLY growth [4][13] - Research and development expenses decreased to $1.3 million in Q4 2024 from $1.5 million in Q4 2023, reflecting a 9% reduction [5] - The net loss for the full year 2024 was $31.4 million, compared to a net loss of $14.4 million in 2023, largely due to changes in warrant liabilities and an impairment of intangible assets [16] Future Outlook - The company anticipates continued revenue growth in 2025, driven by strong demand for ALLY Systems and regulatory clearances in the EU and Taiwan [18] - Revenue growth in the first quarter of 2025 is expected to align with the 27% growth rate achieved in 2024, with acceleration anticipated in subsequent quarters [18] - LENSAR aims to achieve positive Adjusted EBITDA results in 2025, supported by disciplined capital allocation and projected revenue growth from ALLY placements [18]